Senior Tutor and Fellow Carl Heneghan, a GP and Director of the Centre for Evidence-Based Medicine at the University of Oxford appeared before the House of Commons Public Accounts Select Committee on Monday 20th October, which is examining the government’s decision to spend nearly £500m on the antiviral drug Tamiflu in case of a flu pandemic. Carl Heneghan said that the drug did not prevent transmission of flu or reduce dangerous complications, and only slightly reduced symptoms.
The British Academy is a society based in London with the mission to disseminate the research and thinking of academics within the humanities and social sciences, on the controversial issues of the day throughout the country.
Kellogg alumna Amy Price has recently graduated from the MSc in Evidence-Based Healthcare at the Centre for Evidence-Based Medicine within the Nuffield Department of Primary Care Health Sciences at the University of Oxford. The centre is led by Kellogg fellow and Senior Tutor, Carl Heneghan who was also Amy's College Advisor.